Five Reasons Why Clinical Trials Fail And What Pharma is Doing To Fix It

If echo chambers, polarizing politics and solipsism sums up the world in 2018, the art of listening has become gold dust.The pharma industry appears to be bucking the trend however. When it comes to the patient voice, companies are becoming all ears, with patient insights driving internal decisions across the board.We decided to put this proposition to the test.One of pharma ’s perennial thorns is clinical trial recruitment. 86% of clinical trials do not reach recruitment targets within their specified time periods. Patients clearly have their grievances but are pharma companies truly listening? More importantly, are they doing something about it?We enlisted Dominique Hamerlijnck,EUPATI fellow and lung health advocate, to outline five reasons why pharma companies struggle to recruit patients, and then put it to Katie Mazuk, Senior Director, Global Head Investigator and Patient Engagement, Janssen.1. Come again? Most patients are quite willing to engage in clinical trials, but the information given in consent forms can be very confusing, says Hamerlijnck.“On average they are way too long and quite often they are not written at a level of language that is understandable for many patients — not all patients are health literate.”One solution she proposes is to employ specialists to give the information not only in a written format but break the information down into bite sized videos, using language that is is less technical and more patient-friendly; like a news segmen...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news